Cipla   Report issue

For profit Phase 1 Phase 3 Phase 4
Founded: Mumbai India (1935)
Status: No NME R&D (1935)

Organization Overview

First Clinical Trial
2003
NCT00380770
First Marketed Drug
2001
flutamide (eulexin)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

CIPLA | Cipla BioTec | Cipla BioTec Pvt. Ltd. | CIPLA LIMITED | Cipla Ltd. | CIPLA LTD | CIPLA USA | Cipla USA Inc.